CHESTERFIELD, Mo., May 29, 2007 (PRIME NEWSWIRE) -- Reliv International, Inc. (Nasdaq:RELV), a producer and marketer of proprietary nutritional supplements, today announced that its board of directors has authorized $15 million to be used to repurchase Reliv stock. The reauthorization extends for 36 months.
Reliv has been buying back Reliv shares under a previous $15 million repurchasing plan that was authorized in March 2005, and now substantially all those funds have been used.
"Reliv will continue to buy back shares when we believe it is the best use of funds," said Robert L. Montgomery, chairman, chief executive officer and president of Reliv.
About Reliv
Reliv International, Inc., based in suburban St. Louis, Mo., is a developer, manufacturer and marketer of a proprietary line of nutritional supplements addressing basic nutrition, specific wellness needs, weight management and sports nutrition. Reliv sells its products through an international network marketing system of approximately 65,000 independent distributors. Reliv International's common stock trades on NASDAQ under the symbol RELV. Additional information about Reliv International, Inc. can be obtained on the Web at www.reliv.com.
Statements made in this release that are not historical facts are "forward-looking" statements (as defined in the Private Securities Litigation Reform Act of 1995) that involve risks and uncertainties and are subject to change at any time. These forward-looking statements may include, but are not limited to, statements containing words such as "may," "should," "could," "would," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential," "continue," or similar expressions.